Biotechnology, Pharmaceutical and Life Science Reports and Courses

Main Pages

    Best Selling Products

    BioNewsCast Press Release Distribution Service

    BioNewsCast Press Release Distribution Service

     

    3rd Annual Stability Testing Conference

    3rd Annual Stability Testing Conference

     

    Next-Gen Sequencing Trends 2009

    Next-Gen Sequencing Trends 2009

     

    Competitor Analysis: c-MET/HGF Inhibitors

    Competitor Analysis: c-MET/HGF Inhibitors

     

    The Japanese Pharmaceutical Market 2008-2023

    The Japanese Pharmaceutical Market 2008-2023

     

    New Products

    Japanese Pharmaceutical Market 2009-2024

    Japanese Pharmaceutical Market 2009-2024

     

    3rd Annual Lyophilisation Conference

    3rd Annual Lyophilisation Conference

     

    The Global Bioinformatics Market: Market size, forecasts and company profiles

    The Global Bioinformatics Market: Market size, forecasts and company profiles

     

    Pharmaceutical Mergers and Acquisitions (PH133)

    Pharmaceutical Mergers and Acquisitions (PH133)

     

    Pharmaceutical Speaker Programs (PH134) Measuring ROI and Communicating Value

    Pharmaceutical Speaker Programs (PH134) Measuring ROI and Communicating Value

     

    Strategic Clinical Sourcing (PH125)) Managing Costs and CROs

    Strategic Clinical Sourcing (PH125)) Managing Costs and CROs

     

    The Global Analgesics Market 2009-2024

    The Global Analgesics Market 2009-2024

     

    Competitor Analysis: Coagulation Factors

    Competitor Analysis: Coagulation Factors

     

    Competitor Analysis: PDGF-R Agonists and Antagonists

    Competitor Analysis: PDGF-R Agonists and Antagonists

     

    World Market for Addiction Disorders, 2009-2016

    World Market for Addiction Disorders, 2009-2016

     

    BioPortfolio | Select Bioscience Reports |  In Silico ADME/Tox Products Market 2006

    In Silico ADME/Tox Products Market 2006

    In Silico ADME/Tox Products Market 2006


    In Silico predictive ADME/Tox screening is one of the hottest areas in drug discovery. It is widely perceived that the early screening of chemical entities can significantly reduce the expensive costs associated with late stage failures of drugs due to poor ADME/Tox properties. This market research report from Select Biosciences provides an up-to-date overview and analysis of technology, business, regulatory trends and key product profiles.

    In this report Select Biosciences presents an analysis of the In Silico ADME/Tox market landscape. Although, the market is at an embryonic stage of development, the insurgence in the number of companies and products offered to this market clearly reflects significant opportunity.

    Furthermore, in this report qualitative and quantitative market analysis of In Silico ADME/Tox products is presented. Also presented is the potential market opportunity, and the various factors that are driving and/or restraining the growth of this market.

    Key Highlights of this report:

    Overview of the drug discovery process

    Regulatory requirements for drug approval

    The importance of ADME/Tox screening in drug discovery

    Market Drivers and Restraints

    Industry Challenges

    In Silico ADME/Tox screening product analysis

    Quantitative market research

    Competitive Factors

    Published: June 2006, Pages: 180
    Table of Contents
    Table of Contents

    Price
    Single User Print Version $2,500.00   
    Electronic Site License (pdf + one print copy) $3,000.00   



    BioPortfolio uses RBS Worldpay Secure Server for credit card transactions